FindTrial
Sign In

A prospective, randomized, parallel controlled study on the clinical efficacy of Xpert Xpress Flu/RSV in suspected influenza like cases in children

A prospective, randomized, parallel controlled study on the clinical efficacy of Xpert Xpress Flu/RSV in suspected influenza like cases in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110231
Enrollment
Unknown
Registered
2025-10-10
Start date
2021-12-01
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suspected influenza like cases

Interventions

Experimental Group:Xpert Xpress Flu/RSV test
Control Group:FluA and FluB antigen test

Sponsors

Beijing Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1.Fever >=38?, course of disease =28 days, <18 years old; 4.CRP<40mg/L; 5. Complete clinical case data;

Exclusion criteria

Exclusion criteria: 1. Patients who have been confirmed to be infected with a virus; 2. Patients suspected of or confirmed with bacterial infections (urinary tract infections, skin and soft tissue infections, osteomyelitis, bacterial pneumonia, bloodstream infections, etc.);

Design outcomes

Primary

MeasureTime frame
Time to resolution of fever;—

Secondary

MeasureTime frame
Antibiotic prescription rate;Pathogen detection rate;Clinical outcomes;Antibiotic expenses;—

Countries

China

Contacts

Public ContactLiu Gang

Beijing Children's Hospital

liugangbch@sina.com+86 10 5961 7016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026